ArticleJournal of neuroinflammation2026
Integrated omics reveal the effects of vitamin D deficiency on gut microbiota and plasma metabolism in experimental autoimmune uveitis.
Article in Journal of neuroinflammation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Multi‑omics insights into uveitis: From mechanisms to precision medicine (Review).International journal of molecular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Vitamin D deficiency (VD-deficiency) has been implicated in various autoimmune diseases, including uveitis, yet its mechanistic role remains unclear. Emerging evidence suggests that gut microbial dysbiosis and metabolic disturbances may serve as critical intermediates linking VD-deficiency and autoimmune disease pathogenesis. Here, using an experimental autoimmune uveitis (EAU) model induced in B10RIII mice, we demonstrate that VD-deficiency exacerbates EAU severity, accompanied by enhanced Th1 and Th17 responses, suppressed regulatory T cells, and disruption of both intestinal and blood–retinal barrier integrity. Integrated microbiota and metabolomic profiling revealed a coordinated pattern of gut dysbiosis, characterized by enrichment of opportunistic pathogens and depletion of beneficial commensals, together with host metabolic reprogramming in VD-deficient EAU mice. KEGG analysis highlighted disruption of vitamin-related pathways, particularly the vitamin digestion and absorption pathway. Mechanistically, VD-deficiency associated disturbances were linked to LRAT downregulation in retinal pigment epithelial (RPE) cells, accompanied by a pro-inflammatory intraocular microenvironment characterized by increased IL-6 and CXCL family chemokines expression. Gain- and loss-of-function studies in complementary in vivo and in vitro RPE-based models further demonstrated that LRAT functions as a negative regulator of retinal inflammatory responses, with LRAT knockdown enhancing, whereas LRAT overexpression suppressing, the production of IL-6, CXCL1, CXCL2, and CXCL8. Collectively, our findings suggest that VD-deficiency exacerbates autoimmune uveitis by disrupting effector–regulatory T cell balance and compromising blood–retinal barrier and intestinal integrity, accompanied by considerable alterations in gut microbiota and systemic metabolism, while identifying LRAT as a potential regulator linking VD-deficiency to retinal inflammatory amplification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.